IRIS Institutional Research Information System - OPENBS Open Archive UniBS

URBINATI, Chiara Eva
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.865
AS - Asia 3.169
EU - Europa 2.945
SA - Sud America 534
Continente sconosciuto - Info sul continente non disponibili 174
AF - Africa 73
OC - Oceania 27
Totale 12.787
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.667
SG - Singapore 1.258
PL - Polonia 1.161
CN - Cina 960
BR - Brasile 439
UA - Ucraina 375
HK - Hong Kong 326
IT - Italia 321
DE - Germania 289
VN - Vietnam 233
FI - Finlandia 165
GB - Regno Unito 153
FR - Francia 134
RU - Federazione Russa 101
CA - Canada 90
IN - India 89
TR - Turchia 75
IE - Irlanda 69
BD - Bangladesh 59
AR - Argentina 41
NL - Olanda 40
MX - Messico 37
ID - Indonesia 33
SE - Svezia 29
ZA - Sudafrica 28
AU - Australia 26
JP - Giappone 24
CZ - Repubblica Ceca 23
AT - Austria 20
IQ - Iraq 19
ES - Italia 18
EC - Ecuador 16
MA - Marocco 16
IL - Israele 15
CR - Costa Rica 14
JM - Giamaica 14
PK - Pakistan 14
BE - Belgio 11
UZ - Uzbekistan 10
KE - Kenya 9
AZ - Azerbaigian 8
CO - Colombia 8
LT - Lituania 8
SV - El Salvador 8
VE - Venezuela 8
SA - Arabia Saudita 7
CH - Svizzera 6
NI - Nicaragua 6
PE - Perù 6
CL - Cile 5
CW - ???statistics.table.value.countryCode.CW??? 5
EE - Estonia 5
EU - Europa 5
IR - Iran 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
HN - Honduras 4
JO - Giordania 4
MY - Malesia 4
PA - Panama 4
PY - Paraguay 4
GP - Guadalupe 3
GR - Grecia 3
GT - Guatemala 3
HU - Ungheria 3
NG - Nigeria 3
PH - Filippine 3
SC - Seychelles 3
BH - Bahrain 2
BO - Bolivia 2
BZ - Belize 2
CY - Cipro 2
DO - Repubblica Dominicana 2
IS - Islanda 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
MD - Moldavia 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
SN - Senegal 2
AM - Armenia 1
BB - Barbados 1
BS - Bahamas 1
CG - Congo 1
CI - Costa d'Avorio 1
EG - Egitto 1
ET - Etiopia 1
GD - Grenada 1
GI - Gibilterra 1
HT - Haiti 1
KG - Kirghizistan 1
LV - Lettonia 1
LY - Libia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
Totale 12.616
Salva come PNG Salva come JPEG
Città #
Warsaw 1.158
Ashburn 534
Singapore 528
Woodbridge 415
San Jose 403
Fairfield 383
Hong Kong 326
Jacksonville 276
Houston 253
Council Bluffs 221
Beijing 218
Ann Arbor 194
Cambridge 179
Dallas 173
Wilmington 171
Chandler 161
Seattle 154
New York 149
The Dalles 144
Princeton 120
Los Angeles 111
Nanjing 97
Helsinki 95
Dearborn 83
Columbus 79
Lauterbourg 76
Santa Clara 66
Munich 65
Dublin 64
Ho Chi Minh City 63
Istanbul 61
Brescia 60
Milan 58
San Francisco 46
Buffalo 44
Chicago 44
Dong Ket 42
Hanoi 42
São Paulo 39
Moscow 34
Boardman 33
Jinan 33
Lancaster 32
Phoenix 32
Shanghai 32
Brooklyn 31
Nanchang 31
Shenyang 30
Des Moines 29
London 27
Montreal 25
San Diego 25
Redondo Beach 24
Toronto 23
Jiaxing 22
North Bergen 22
Tianjin 22
Tokyo 22
Atlanta 21
Changsha 21
Orem 21
Chennai 19
Nuremberg 19
Kunming 18
Hangzhou 17
Hebei 17
Jakarta 17
Manchester 17
Florence 16
Rio de Janeiro 16
Turku 16
Verona 16
Zhengzhou 16
Frankfurt am Main 15
Johannesburg 15
Olomouc 15
Poplar 14
Stockholm 14
Denver 13
Groningen 13
Haikou 12
Lallio 12
Mumbai 12
San José 12
Amsterdam 11
Guangzhou 11
Augusta 10
Brasília 10
Brussels 10
Dhaka 9
Guayaquil 9
Las Vegas 9
Leawood 9
Mexico City 9
San Mateo 9
Baku 8
Belo Horizonte 8
Boston 8
Curitiba 8
Hải Dương 8
Totale 8.484
Salva come PNG Salva come JPEG
Nome #
Bridging the past and the future of virology: Surface plasmon resonance as a powerful tool to investigate virus/host interactions. 376
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 333
Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use 329
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 309
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. 295
Speeding Up the Identification of Cystic Fibrosis Transmembrane Conductance Regulator-Targeted Drugs: An Approach Based on Bioinformatics Strategies and Surface Plasmon Resonance 292
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 284
In silico drug repositioning on F508del-CFTR: A proof-of-concept study on the AIFA library 275
Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of HIV-1 Tat and gp120 proteins 239
Sialic acid associated to αvβ3 integrin mediates HIV-1 Tat interaction and endothelial cell proangiogenic activation. 239
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. 234
Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin: IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF p17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS 230
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 224
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 215
Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells. 202
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis 198
Exploitation of a novel biosensor based on the full-length human F508del-CFTR with computational studies, biochemical and biological assays for the characterization of a new Lumacaftor/Tezacaftor analogue 196
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 184
Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 183
Sialic acid as a target for the development of novel antiangiogenic strategies 181
Surface functionalization of extracellular vesicle nanoparticles with antibodies: a first study on the protein corona "variable" 174
Subcellular localization and biological activity of a Mr 18,000 basic fibroblast growth factor: site directed mutagenesis of a putative nuclear translocation sequence 170
Cutting edge: proangiogenic properties of alternatively activated dendritic cells. 170
Human basic fibroblast growth factor: structure- function relationship of an angiogenic molecule 165
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures 163
Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway 161
Cell membrane GM1 ganglioside is a functional co-receptor for Fibroblast growth factor-2. 159
alpha v beta 3 integrin-dependent activation of focal adhesion kinase mediates NF-kB activation and motogenic activity by HIV-1 Tat in endothelial cells 157
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 151
Polysulfated/sulfonated compounds for the development of drugs at the crossroad of viral infection and oncogenesis 144
Basic fibroblast growth factor and endothelial cells: receptor interaction, signal trasduction, cellular response. Dissociation of the mitogenic activity of bFGF from its plasminigen activator-inducing activity 142
Activation of endothelial cell mitogen activated protein kinase ERK 1/2 by extracellular HIV-1 Tat protein 140
Expression of basic fibroblast growth factor and its receptors in human fetal microglia cells. 140
rescuing defective CFTR applying a drug repositioning strategy based on computational studies, surface plasmon resonance and cell based assays 136
Recent Strategic Advances in CFTR Drug Discovery: An Overview 136
Substrate-immobilized HIV-1 Tat drives VEGFR2/αvβ3 integrin complex formation and polarization in endothelial cells 133
Angiogenic growth factor-endothelial cell interaction: receptor binding and cell internalization techniques 129
Role of heparan sulfate proteoglycans in HIV-1 Tat-induced transendothelial migration of lymphoid cells 127
endothelial cell adhesion to HIV-1 Tat: cross talk between integrin alphav beta3 and vascular endothelial growth factor receptor-2 (KDR) 126
Polyanionic drugs and viral oncogenesis: a novel approach to control virus infection, tumor-associated inflammation and angiogenesis 125
Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives. 125
Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain 123
Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: role of the low affinity heparin-like bFGF-receptors 123
The basic domain in HIV-1 Tat as a target for polysulfated heparin-mimicking extracellular Tat antagonists 120
Functional domains of basic fibroblast growth factor. Possible role of Asp-Gly-Arg sequences in the mitogenic activity of bFGF. 120
Flk-1/KDR and v3 recruitment and cross-talk at the basal aspect of HIV-1 Tat-adherent endothelial cells drives pp60src/ERK1/2 activation, cytoskeleton organization and pro-angiogenic activation 114
Discovery of novel VX-809 hybrid derivatives as F508del-CFTR correctors by molecular modeling, chemical synthesis and biological assays 113
Thrombospondin-1: the paradigm of antiangiogenic agents endowed with multiple mechanisms of action 112
An innovative strategy to investigate microbial protein modifications in a reliable fast and sensitive way: A therapy oriented proof of concept based on UV-C irradiation of SARS-CoV-2 spike protein 111
HIV-1 Tat and heparan sulfate proteoglycans: a novel mechanism of lymphocyte adhesion and migration across the endothelium 110
Thrombospondin/HIV-1 Tat protein interaction: modulation of the biologiocal activity of extracellular Tat 110
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumor cells 110
Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin 110
THE ROLE OF GLYCOSAMINOGLYCANS IN SPIKE SARS-CoV-2 INFECTION: FROM A MODEL FOR HEPARAN SULFATES TO A STARTING STRUCTURE FOR ANTIVIRALS 109
Virtual Drug Repositioning as a Tool to Identify Natural Small Molecules That Synergize with Lumacaftor in F508del-CFTR Binding and Rescuing 108
Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorionallantoic membranes 108
Interaction of high molecular weight basic fibroblast growth factor (bFGF) with endothelium: biological activity and intracellular fate of human recombinant Mr 24,000 bFGF 107
VEGFR2 and v3 recruitment and cross-talk at the basal aspect of HIV-1 Tat-adherent endothelial cells drives pp60src/ERK1/2 activation, cytoskeleton organization and pro-angiogenic activation 107
Design and Validation of Broad-Spectrum Antiviral Compounds Against SARS-CoV-2 105
Role of Syndecan-1 in HIV-1 Tat-induced chemotaxis of lymphoid cells 103
Inhibition of HIV-Tat angiogenic activity targeting HSPGs biosynthesis enzymes 103
The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms 101
HIV-1 Tat and heparan sulfate proteoglycan interact to mediate lymphocyte adhesion and migration across the endothelium 98
Validation of plasmonic-based biosensors for rapid and in depth characterization of monoclonal antibodies directed against rabbit haemorrhagic and foot-and-mouth disease viruses in biological samples 97
HIV-1 Tat and Heparan Sulfate Proteoglycans Orchestrate the Setup of in Cis and in Trans Cell-Surface Interactions Functional to Lymphocyte Trans-Endothelial Migration 97
HIV-1 Tat e iL monocita/macrofago: dall'interazione cellula/proteina all'insorgenza delle patologie associate all'AIDS 96
Role of thrombospondin-1 in the microenvironment of osteolytic bone metastases 95
HIV-1 Tat/heparin interaction: translating new insight from molecular modelling to the comprehension of its biological functions 94
UV-C EXPOSURE SUGGESTS A SARS-CoV-2 SPIKE PROTEIN ANTIVIRAL STRATEGY BASED ON REDUCING AGENTS 90
DOES NICOTINAMIDE COMBINES WITH LUMACAFTOR TO IMPROVE F508del-CFTR RESCUE? 89
multidisciplinary approaches to rescue CFTR impairments by drug repositioning 87
The role of heparin in spike SARS-COV-2 infection: From a model for heparan sulfates to a starting structure for antivirals 86
Glycomics and angiogenesis: biological implications and therapeutical exploiting 86
heparan sulfate proteoglycans/HIV-1 Tat interaction: a mechanical and functional bridge between lymphoid and endothelial cells 84
implementation of a new computational protocol based on incremental docking to study interaction of long sugar chain with proteins: heparin/HIV-1 p17 case study 83
Exploring Alternative BAG3 Targeting Approaches for pediatric medulloblastoma: From small molecules lead optimization to Fragment-Based Drug Discovery 83
Design and Validation of Broad-Spectrum Antiviral Compounds Against SARS-CoV-2 83
Molecular dynamics simulations to investigate the dynamics and mechanism of action of carbohydrate-based polymers 81
rescuing defective CFTR applying a drug repositioning strategy based on computational studies, surface plasmon resonance and cell based assays 80
rescuing defective CFTR applying a drug repositioning strategy based on computational studies, surface plasmon resonance and cell based assays 79
Computational evaluation of the synergic effect of a small molecule on Lumacaftor F508del-CFTR rescue ability 79
HIV-1 Tat and heparan sulfate proteoglycans orchestrate the setup of in cis and in trans cells surface interactions functional to lymphocyte trans-endothelial migration 72
implementation of an incremental docking method to study long sugar chains interactions with proteins 71
HIV-of its biological functions1 Tat/heparin interaction: translating new insight from molecular modelling to the comprehension 71
heparin and heparan sulfate proteoglycans promotes hiv-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 70
Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity 68
Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity 66
Role of thrombospondin-1 in the microenvironment of osteolytic bone metastases 65
A drug repositioning pipeline to evaluate a synergic effect of small molecules on CFTR drugs 63
direct inhibition of the VEGF/VEGFR system by the Eph/Ephrin antagonist UniPR1331: a new dual-acting antiangiogenic compound 61
Design, synthesis and biological evaluation of novel 2,4-thiazolidinedione derivatives able to target the human BAG3 protein 55
K5 polysaccharides inhibit SARS-CoV-2 infection by preventing spike-proteolytic priming 40
Totale 12.787
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.778
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.778
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022393 0 0 0 0 5 29 40 40 24 75 44 136
2022/2023438 64 19 26 19 29 125 7 46 63 3 12 25
2023/2024618 36 8 63 35 28 122 17 20 139 16 17 117
2024/20251.798 20 10 7 188 94 109 117 54 139 246 524 290
2025/20263.903 389 521 355 570 399 288 591 134 228 273 114 41
2026/2027928 135 136 253 387 17 0 0 0 0 0 0 0
Totale 12.787